Review



mesenchymal stem cell basal medium  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC mesenchymal stem cell basal medium
    Mesenchymal Stem Cell Basal Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 512 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mesenchymal stem cell basal medium/product/ATCC
    Average 99 stars, based on 512 article reviews
    mesenchymal stem cell basal medium - by Bioz Stars, 2026-06
    99/100 stars

    Images



    Similar Products

    99
    ATCC mesenchymal stem cell basal medium
    Mesenchymal Stem Cell Basal Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mesenchymal stem cell basal medium/product/ATCC
    Average 99 stars, based on 1 article reviews
    mesenchymal stem cell basal medium - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    86
    Dawley Inc bone marrow stem cells bmscs
    Bone Marrow Stem Cells Bmscs, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bone marrow stem cells bmscs/product/Dawley Inc
    Average 86 stars, based on 1 article reviews
    bone marrow stem cells bmscs - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc mesenchymal stem cells mscs
    RNM composite gel mitigates radiation-induced damage in vitro (A) Viability of HEI-OC1 cells after different doses of radiation treatment, detected by CCK-8 assay. (B) Apoptosis of HEI-OC1 cells analyzed by flow cytometry after radiation exposure and subsequent transwell co-culture with RN gel, <t>MSCs,</t> or the RNM gel system. Data are represented as the mean ± SEM. ( N = 3, t test). (C) Distribution of γ-H2AX (red) in HEI-OC1 cells observed under a confocal microscope after radiation exposure and intervention with RN, MSCs, or RNM. Scale bars, 10 μm. (D, E, G, and H) mRNA expression levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in mouse cochlear tissues evaluated by real-time qPCR after intratympanic injection of RN, MSCs, or RNM hydrogel following radiation exposure. Data are represented as the mean ± SEM ( N = 3, t test). (F) Intracellular ROS levels in HEI-OC1 cells monitored using the DCFH-DA fluorescent probe and flow cytometry after radiation exposure and intervention with RN, MSCs, or RNM. Data are represented as the mean ± SEM ( N = 3, t test). (I) mRNA expression levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in HEI-OC1 cells detected by real-time qPCR after radiation exposure and intervention with RN, MSCs, or RNM. Data are represented as the mean ± SEM ( N = 3, t test). Significant differences between the groups are indicated by ∗ for p < 0.05, ∗∗ for p < 0.01, ∗∗∗ for p < 0.001, and ∗∗∗∗ for p < 0.0001.
    Mesenchymal Stem Cells Mscs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mesenchymal stem cells mscs/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    mesenchymal stem cells mscs - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc synovial mesenchymal stem cells
    A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the <t>mesenchymal</t> marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).
    Synovial Mesenchymal Stem Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synovial mesenchymal stem cells/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    synovial mesenchymal stem cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Geron Bio embryonic stem cells escs
    Pluripotency and differentiating capacity <t>of</t> <t>embryonic</t> stem cells <t>(ESCs).</t> ESCs are created from the inner cell mass (ICM) of the blastocyst stage. They can develop into all three germ layers: the ectoderm (which later gives rise to the brain, skin, and eyes), the endoderm (which gives rise to the lungs, liver, and gut), and the mesoderm (which gives rise to the bones, blood, and muscles). ESCs undergo in vitro differentiation using specific protocols, forming embryoid bodies that mimic early-stage embryogenesis. They may also be implanted in vivo, where they can assist in tissue regeneration. Still, they may, in rare cases, develop into teratomas: complex tumors that contain tissues from all three germ layers. ESCs may also assist in repairing organs, although they may be unregulated and pose risks such as teratocarcinoma.
    Embryonic Stem Cells Escs, supplied by Geron Bio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/embryonic stem cells escs/product/Geron Bio
    Average 86 stars, based on 1 article reviews
    embryonic stem cells escs - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc rat bone marrow mesenchymal stem cells mscs
    Schematic diagram of the ACP@Z@C hydrogel for periodontitis treatment. The BA-modified CC hydrogel for the delivery of CAPE-loading MOF, which accomplishes the targeted and controlled release of ZIF-8@CAPE in oral microenvironment. The released ZIF-8@CAPE interferes with multiple periodontitis-driven factors, including anti-bacteria, ROS-scavenging, and anti-inflammation. These potency transforms into periodontal tissue regeneration via rescuing the impaired osteogenic differentiation of <t>MSCs.</t>
    Rat Bone Marrow Mesenchymal Stem Cells Mscs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat bone marrow mesenchymal stem cells mscs/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    rat bone marrow mesenchymal stem cells mscs - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc rat bone marrow mesenchymal stem cells
    Schematic diagram of the ACP@Z@C hydrogel for periodontitis treatment. The BA-modified CC hydrogel for the delivery of CAPE-loading MOF, which accomplishes the targeted and controlled release of ZIF-8@CAPE in oral microenvironment. The released ZIF-8@CAPE interferes with multiple periodontitis-driven factors, including anti-bacteria, ROS-scavenging, and anti-inflammation. These potency transforms into periodontal tissue regeneration via rescuing the impaired osteogenic differentiation of <t>MSCs.</t>
    Rat Bone Marrow Mesenchymal Stem Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat bone marrow mesenchymal stem cells/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    rat bone marrow mesenchymal stem cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Fisher Scientific experimental section 1 human induced pluripotent stem cell ipsc culture
    Schematic diagram of the ACP@Z@C hydrogel for periodontitis treatment. The BA-modified CC hydrogel for the delivery of CAPE-loading MOF, which accomplishes the targeted and controlled release of ZIF-8@CAPE in oral microenvironment. The released ZIF-8@CAPE interferes with multiple periodontitis-driven factors, including anti-bacteria, ROS-scavenging, and anti-inflammation. These potency transforms into periodontal tissue regeneration via rescuing the impaired osteogenic differentiation of <t>MSCs.</t>
    Experimental Section 1 Human Induced Pluripotent Stem Cell Ipsc Culture, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/experimental section 1 human induced pluripotent stem cell ipsc culture/product/Fisher Scientific
    Average 86 stars, based on 1 article reviews
    experimental section 1 human induced pluripotent stem cell ipsc culture - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    RNM composite gel mitigates radiation-induced damage in vitro (A) Viability of HEI-OC1 cells after different doses of radiation treatment, detected by CCK-8 assay. (B) Apoptosis of HEI-OC1 cells analyzed by flow cytometry after radiation exposure and subsequent transwell co-culture with RN gel, MSCs, or the RNM gel system. Data are represented as the mean ± SEM. ( N = 3, t test). (C) Distribution of γ-H2AX (red) in HEI-OC1 cells observed under a confocal microscope after radiation exposure and intervention with RN, MSCs, or RNM. Scale bars, 10 μm. (D, E, G, and H) mRNA expression levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in mouse cochlear tissues evaluated by real-time qPCR after intratympanic injection of RN, MSCs, or RNM hydrogel following radiation exposure. Data are represented as the mean ± SEM ( N = 3, t test). (F) Intracellular ROS levels in HEI-OC1 cells monitored using the DCFH-DA fluorescent probe and flow cytometry after radiation exposure and intervention with RN, MSCs, or RNM. Data are represented as the mean ± SEM ( N = 3, t test). (I) mRNA expression levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in HEI-OC1 cells detected by real-time qPCR after radiation exposure and intervention with RN, MSCs, or RNM. Data are represented as the mean ± SEM ( N = 3, t test). Significant differences between the groups are indicated by ∗ for p < 0.05, ∗∗ for p < 0.01, ∗∗∗ for p < 0.001, and ∗∗∗∗ for p < 0.0001.

    Journal: iScience

    Article Title: Fabrication of RADA32/Ngf_EE/MSCs composite hydrogel and its protective mechanism against radiation-induced ototoxicity

    doi: 10.1016/j.isci.2026.115723

    Figure Lengend Snippet: RNM composite gel mitigates radiation-induced damage in vitro (A) Viability of HEI-OC1 cells after different doses of radiation treatment, detected by CCK-8 assay. (B) Apoptosis of HEI-OC1 cells analyzed by flow cytometry after radiation exposure and subsequent transwell co-culture with RN gel, MSCs, or the RNM gel system. Data are represented as the mean ± SEM. ( N = 3, t test). (C) Distribution of γ-H2AX (red) in HEI-OC1 cells observed under a confocal microscope after radiation exposure and intervention with RN, MSCs, or RNM. Scale bars, 10 μm. (D, E, G, and H) mRNA expression levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in mouse cochlear tissues evaluated by real-time qPCR after intratympanic injection of RN, MSCs, or RNM hydrogel following radiation exposure. Data are represented as the mean ± SEM ( N = 3, t test). (F) Intracellular ROS levels in HEI-OC1 cells monitored using the DCFH-DA fluorescent probe and flow cytometry after radiation exposure and intervention with RN, MSCs, or RNM. Data are represented as the mean ± SEM ( N = 3, t test). (I) mRNA expression levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in HEI-OC1 cells detected by real-time qPCR after radiation exposure and intervention with RN, MSCs, or RNM. Data are represented as the mean ± SEM ( N = 3, t test). Significant differences between the groups are indicated by ∗ for p < 0.05, ∗∗ for p < 0.01, ∗∗∗ for p < 0.001, and ∗∗∗∗ for p < 0.0001.

    Article Snippet: Mouse bone marrow-derived mesenchymal stem cells (MSCs) and the mouse monocyte/macrophage cell line RAW264.7 were purchased from Procell Life Science & Technology Co., Ltd.

    Techniques: In Vitro, CCK-8 Assay, Flow Cytometry, Co-Culture Assay, Microscopy, Expressing, Injection

    In vivo protective effects of RNM composite gel (A) Schematic of the in vivo experimental timeline and anatomical images of the mouse cochlea under a dissection microscope. (a, oval window; b, cochlear labyrinth.). (B–G) ABR tests performed 2 days before radiation exposure and 3, 7, and 14 days after drug administration to assess hearing function in mice. (H) Left: Confocal microscopy images of the cochlear basilar membrane 14 days after radiation exposure and intratympanic injection of RN, MSCs, or RNM hydrogel, stained with FITC-phalloidin to label hair cells. Scale bars, 20 μm. Right: Quantitative comparison of outer hair cell (OHC) and inner hair cell (IHC) survival rates post-intervention. Data are represented as the mean ± SEM ( N = 3, t test). (I) H&E staining images of mouse cochlear tissues extracted 14 days after radiation exposure and intratympanic injection of RN, MSCs, or RNM hydrogel. Data are represented as the mean ± SEM ( N = 3, t test). Scale bars, 20 μm. Significant differences between the groups are indicated by ∗ for p < 0.05, ∗∗ for p < 0.01, ∗∗∗ for p < 0.001, and ∗∗∗∗ for p < 0.0001.

    Journal: iScience

    Article Title: Fabrication of RADA32/Ngf_EE/MSCs composite hydrogel and its protective mechanism against radiation-induced ototoxicity

    doi: 10.1016/j.isci.2026.115723

    Figure Lengend Snippet: In vivo protective effects of RNM composite gel (A) Schematic of the in vivo experimental timeline and anatomical images of the mouse cochlea under a dissection microscope. (a, oval window; b, cochlear labyrinth.). (B–G) ABR tests performed 2 days before radiation exposure and 3, 7, and 14 days after drug administration to assess hearing function in mice. (H) Left: Confocal microscopy images of the cochlear basilar membrane 14 days after radiation exposure and intratympanic injection of RN, MSCs, or RNM hydrogel, stained with FITC-phalloidin to label hair cells. Scale bars, 20 μm. Right: Quantitative comparison of outer hair cell (OHC) and inner hair cell (IHC) survival rates post-intervention. Data are represented as the mean ± SEM ( N = 3, t test). (I) H&E staining images of mouse cochlear tissues extracted 14 days after radiation exposure and intratympanic injection of RN, MSCs, or RNM hydrogel. Data are represented as the mean ± SEM ( N = 3, t test). Scale bars, 20 μm. Significant differences between the groups are indicated by ∗ for p < 0.05, ∗∗ for p < 0.01, ∗∗∗ for p < 0.001, and ∗∗∗∗ for p < 0.0001.

    Article Snippet: Mouse bone marrow-derived mesenchymal stem cells (MSCs) and the mouse monocyte/macrophage cell line RAW264.7 were purchased from Procell Life Science & Technology Co., Ltd.

    Techniques: In Vivo, Dissection, Microscopy, Confocal Microscopy, Membrane, Injection, Staining, Comparison

    Immunomodulatory mechanism of RNM composite gel (A and B) Flow cytometric analysis of CD86 and CD206 expression in RAW264.7 macrophages after irradiation and co-culture with RN, MSCs, or RNM composite gel in a transwell system (macrophages in lower chamber). Data are represented as the mean ± SEM ( N = 3, t test). (C) Immunofluorescence staining of F4/80 (red) on cochlear sections. Scale bars, 50 μm (a, spiral ganglion; b, basilar membrane; c, stria vascularis; d, spiral ligament). (D) Apoptosis of HEI-OC1 cells analyzed by flow cytometry after radiation exposure and intervention. Data are represented as the mean ± SEM ( N = 3, t test). (E) Expression level of p-p65, a key marker of NF-κB pathway activation, in macrophages after radiation exposure and drug intervention. Data are represented as the mean ± SEM ( N = 3, t test). Significant differences between the groups are indicated by ∗ for p < 0.05, ∗∗ for p < 0.01, ∗∗∗ for p < 0.001, and ∗∗∗∗ for p < 0.0001.

    Journal: iScience

    Article Title: Fabrication of RADA32/Ngf_EE/MSCs composite hydrogel and its protective mechanism against radiation-induced ototoxicity

    doi: 10.1016/j.isci.2026.115723

    Figure Lengend Snippet: Immunomodulatory mechanism of RNM composite gel (A and B) Flow cytometric analysis of CD86 and CD206 expression in RAW264.7 macrophages after irradiation and co-culture with RN, MSCs, or RNM composite gel in a transwell system (macrophages in lower chamber). Data are represented as the mean ± SEM ( N = 3, t test). (C) Immunofluorescence staining of F4/80 (red) on cochlear sections. Scale bars, 50 μm (a, spiral ganglion; b, basilar membrane; c, stria vascularis; d, spiral ligament). (D) Apoptosis of HEI-OC1 cells analyzed by flow cytometry after radiation exposure and intervention. Data are represented as the mean ± SEM ( N = 3, t test). (E) Expression level of p-p65, a key marker of NF-κB pathway activation, in macrophages after radiation exposure and drug intervention. Data are represented as the mean ± SEM ( N = 3, t test). Significant differences between the groups are indicated by ∗ for p < 0.05, ∗∗ for p < 0.01, ∗∗∗ for p < 0.001, and ∗∗∗∗ for p < 0.0001.

    Article Snippet: Mouse bone marrow-derived mesenchymal stem cells (MSCs) and the mouse monocyte/macrophage cell line RAW264.7 were purchased from Procell Life Science & Technology Co., Ltd.

    Techniques: Expressing, Irradiation, Co-Culture Assay, Immunofluorescence, Staining, Membrane, Flow Cytometry, Marker, Activation Assay

    A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the mesenchymal marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).

    Journal: Regenerative Therapy

    Article Title: Effects and mechanisms of synovial mesenchymal stem cell–derived extracellular vesicular LncRNA-SNHG14 on chondrocyte injury

    doi: 10.1016/j.reth.2026.101122

    Figure Lengend Snippet: A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the mesenchymal marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).

    Article Snippet: Primary rat chondrocytes (Catalog No. CP-R087, 5 × 10 5 Cells/T25) and synovial mesenchymal stem cells (SMSC, Catalog No. CP-R304, 5 × 10 5 Cells/T25) were purchased from Wuhan Procell Life Science & Technology Co., Ltd.

    Techniques: Inverted Microscopy, Marker

    Pluripotency and differentiating capacity of embryonic stem cells (ESCs). ESCs are created from the inner cell mass (ICM) of the blastocyst stage. They can develop into all three germ layers: the ectoderm (which later gives rise to the brain, skin, and eyes), the endoderm (which gives rise to the lungs, liver, and gut), and the mesoderm (which gives rise to the bones, blood, and muscles). ESCs undergo in vitro differentiation using specific protocols, forming embryoid bodies that mimic early-stage embryogenesis. They may also be implanted in vivo, where they can assist in tissue regeneration. Still, they may, in rare cases, develop into teratomas: complex tumors that contain tissues from all three germ layers. ESCs may also assist in repairing organs, although they may be unregulated and pose risks such as teratocarcinoma.

    Journal: Regenerative Therapy

    Article Title: Engineering cardiac regeneration using stem cells: Cellular sources, differentiation signatures, targeted delivery, and functional recovery

    doi: 10.1016/j.reth.2026.101120

    Figure Lengend Snippet: Pluripotency and differentiating capacity of embryonic stem cells (ESCs). ESCs are created from the inner cell mass (ICM) of the blastocyst stage. They can develop into all three germ layers: the ectoderm (which later gives rise to the brain, skin, and eyes), the endoderm (which gives rise to the lungs, liver, and gut), and the mesoderm (which gives rise to the bones, blood, and muscles). ESCs undergo in vitro differentiation using specific protocols, forming embryoid bodies that mimic early-stage embryogenesis. They may also be implanted in vivo, where they can assist in tissue regeneration. Still, they may, in rare cases, develop into teratomas: complex tumors that contain tissues from all three germ layers. ESCs may also assist in repairing organs, although they may be unregulated and pose risks such as teratocarcinoma.

    Article Snippet: Embryonic Stem Cells (ESCs) , - Regeneration of damaged myocardium - replacement of cardiomyocytes , Differentiation into functional cardiomyocytes , Geron Corporation studies (preclinical models) [ ] .

    Techniques: Muscles, In Vitro, In Vivo

    Schematic diagram of the ACP@Z@C hydrogel for periodontitis treatment. The BA-modified CC hydrogel for the delivery of CAPE-loading MOF, which accomplishes the targeted and controlled release of ZIF-8@CAPE in oral microenvironment. The released ZIF-8@CAPE interferes with multiple periodontitis-driven factors, including anti-bacteria, ROS-scavenging, and anti-inflammation. These potency transforms into periodontal tissue regeneration via rescuing the impaired osteogenic differentiation of MSCs.

    Journal: Materials Today Bio

    Article Title: Targeted antibacterial and mesenchymal stem cell-modulatory hydrogel for periodontitis treatment

    doi: 10.1016/j.mtbio.2026.103043

    Figure Lengend Snippet: Schematic diagram of the ACP@Z@C hydrogel for periodontitis treatment. The BA-modified CC hydrogel for the delivery of CAPE-loading MOF, which accomplishes the targeted and controlled release of ZIF-8@CAPE in oral microenvironment. The released ZIF-8@CAPE interferes with multiple periodontitis-driven factors, including anti-bacteria, ROS-scavenging, and anti-inflammation. These potency transforms into periodontal tissue regeneration via rescuing the impaired osteogenic differentiation of MSCs.

    Article Snippet: Rat bone marrow mesenchymal stem cells (MSCs) was purchased from Procell (Wuhan, China).

    Techniques: Modification, Bacteria

    Inhibiting inflammatory factor by adjusting mitochondrial dysfunction via SIRT1/p-AMPK/PGC-1α pathway. (A) Schematic illustration of the molecular mechanism by which Z@C regulates mitochondrial dysfunction and suppresses inflammatory factor production in MSCs. (B) Representative western blot bands and quantitative analysis of (C) SIRT1, (D) p-AMPK, (E) PGC-1α, (F) NLRP3, and (G) Pro-Caspase-1 protein expression. Data were presented as mean ± SD, n = 3, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Expression levels of (H) SIRT1, (I) PGC-1α, (J) NLRP3, (K) IL-1β, (L) IL-6, and (M) TNF-α following Z@C treatment. Data were presented as mean ± SD, n = 5, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. (N) Immunofluorescence staining of SIRT1 expression in MSCs following different groups and (O) quantitative analysis. Data were presented as mean ± SD, n = 3, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

    Journal: Materials Today Bio

    Article Title: Targeted antibacterial and mesenchymal stem cell-modulatory hydrogel for periodontitis treatment

    doi: 10.1016/j.mtbio.2026.103043

    Figure Lengend Snippet: Inhibiting inflammatory factor by adjusting mitochondrial dysfunction via SIRT1/p-AMPK/PGC-1α pathway. (A) Schematic illustration of the molecular mechanism by which Z@C regulates mitochondrial dysfunction and suppresses inflammatory factor production in MSCs. (B) Representative western blot bands and quantitative analysis of (C) SIRT1, (D) p-AMPK, (E) PGC-1α, (F) NLRP3, and (G) Pro-Caspase-1 protein expression. Data were presented as mean ± SD, n = 3, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Expression levels of (H) SIRT1, (I) PGC-1α, (J) NLRP3, (K) IL-1β, (L) IL-6, and (M) TNF-α following Z@C treatment. Data were presented as mean ± SD, n = 5, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. (N) Immunofluorescence staining of SIRT1 expression in MSCs following different groups and (O) quantitative analysis. Data were presented as mean ± SD, n = 3, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

    Article Snippet: Rat bone marrow mesenchymal stem cells (MSCs) was purchased from Procell (Wuhan, China).

    Techniques: Western Blot, Expressing, Immunofluorescence, Staining